Full Text View
Tabular View
No Study Results Posted
Related Studies
Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer
This study has been withdrawn prior to enrollment.
( No accrual in initial period, PI decided to close study. )
Study NCT01478308   Information provided by New Mexico Cancer Care Alliance

First Received on September 2, 2011.   Last Updated on March 5, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Prostate Cancer
Additional conditions recognized in this trial
Prostatic Neoplasms
More general conditions related to this trial
Genital Diseases, Male
Genital Neoplasms, Male
Neoplasms
Neoplasms by Site
Prostatic Diseases
Urogenital Neoplasms
Interventions listed in this trial
Metformin hydrochloride
Docetaxel
Prednisone
Additional drug interventions recognized in this trial
Metformin
More general drug interventions related to this trial
Anti-Inflammatory Agents
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Hypoglycemic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
New Mexico Cancer Care Alliance


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services